Updated October 25, 2026
Medical device translation is the controlled translation and localization of labeling, instructions for use (IFUs), software, safety information, technical documentation, and other device content for each target market. It helps manufacturers meet local language requirements, protect users, maintain consistent product information, and support regulatory submissions and commercial releases.
A reliable program does more than translate words. It connects regulatory intelligence, medical and technical expertise, approved terminology, independent review, document control, in-context testing, and release evidence. The exact process should reflect the device, intended user, risk class, market, content type, and applicable quality system.
What Is Medical Device Translation?
Medical device translation adapts regulated and operational content without changing the device’s intended meaning, safety information, performance claims, or instructions. It may involve straightforward document translation, multilingual desktop publishing, software localization, terminology management, linguistic testing, or a controlled combination of these services.
The intended audience matters. A surgeon, laboratory professional, service engineer, patient, caregiver, regulator, and distributor need different levels of technical detail and plain-language support. The same approved concept should remain consistent across every channel while the wording stays appropriate for its user and context.
Which Medical Device Content May Need Translation?
| Content group | Common examples | Primary translation risk |
|---|---|---|
| Labeling and user information | Labels, packaging, IFUs, quick-start guides, warnings, implant cards | Incorrect use or noncompliance |
| Software and digital content | Device UI, SaMD, patient apps, clinician portals, alarms, help content | Truncation, ambiguity, or unsafe interaction |
| Regulatory and technical files | Declarations, clinical evaluation, risk files, specifications, submissions | Review delays or inconsistent evidence |
| Clinical content | Investigation plans, consent forms, questionnaires, safety reports | Participant misunderstanding or unreliable data |
| Quality and manufacturing | SOPs, work instructions, CAPA records, supplier documents, training | Process variation or audit findings |
| Post-market content | Complaints, field safety notices, recalls, vigilance and support materials | Delayed or unclear safety communication |
| Commercial and training | Websites, brochures, e-learning, sales aids and product demonstrations | Claims that diverge from approved labeling |
Create a market-and-content matrix before work begins. For every deliverable, identify the destination country, required language, intended user, source revision, regulatory purpose, file format, reviewer, approval route, release date, and related device content.
Medical Device Translation Requirements in 2026
There is no single worldwide language rule. Manufacturers must confirm the regulations, guidance, standards, competent-authority expectations, and national provisions that apply to the specific device and market. Translation supports compliance, but the manufacturer remains responsible for the released content.
European Union: MDR, national languages, and GUIs
Under Regulation (EU) 2017/745, information supplied with a device must be provided in the official Union language or languages determined by the Member State where the device reaches the user or patient. Requirements can differ by country, document, and audience. The European Commission’s MDR language-requirements overview includes current country tables for labels, IFUs, declarations, field safety notices, implant cards, conformity-assessment documents, and graphic user interfaces.
Do not treat “Europe” as one language package. Build the language list from the launch markets and intended users, then verify it against current national law. Professional-use devices may receive different treatment from patient or lay-user devices in some countries.
Electronic instructions for use
Commission Implementing Regulation (EU) 2021/2226 sets conditions for supplying eligible medical-device IFUs electronically instead of on paper. The rules include a manufacturer risk assessment, access and website controls, paper copies on request, protection against unauthorized changes, and availability of previous electronic versions. The eIFU must be accessible in the language or languages required by the Member State. Review the current consolidated eIFU regulation before release.
United States: FDA labeling and the QMSR
FDA medical-device labeling requirements are primarily found in 21 CFR Part 801, with additional rules for specific device categories. FDA states that labeling is generally required in English, with limited territorial exceptions. If a label or labeling includes a representation in another language, all required labeling must also appear in that language. See the FDA’s general device-labeling requirements.
The FDA Quality Management System Regulation became effective on February 2, 2026. It incorporates ISO 13485:2016 by reference and includes U.S. supplemental provisions for device labeling and packaging controls. Manufacturers should place translation, review, proofreading, approval, change control, and release records within the applicable quality-system processes. Consult the FDA’s current QMSR resources.
Regulations and standards are not interchangeable. ISO 13485 can shape the quality system, while market-specific laws determine what must be translated and accepted. Confirm requirements with qualified regulatory professionals rather than relying on a generic language list.
The Main Medical Device Translation Challenges
- Country-by-country variation: language obligations and accepted formats change by market and user type.
- Safety-critical terminology: one inconsistent component name, warning, unit, or operating step can create user risk.
- Connected content: IFUs, labels, software, training, and support materials must remain synchronized.
- Source changes: late revisions multiply across languages, layouts, screenshots, approvals, and release packages.
- Layout and software constraints: text expansion, fonts, bidirectional scripts, variables, and small displays can hide or distort meaning.
- Reviewer variation: uncontrolled preference edits can replace approved terms and introduce new errors.
- Traceability: teams must show which source was translated, who reviewed it, what changed, and what was released.
A Risk-Based Medical Device Translation Workflow
1. Define markets, users, and regulatory scope
Confirm where the device will be supplied, who will use it, which content accompanies it, and which authority or notified body will review it. Assign regulatory, quality, product, engineering, localization, and final-approval responsibilities.
2. Classify content by risk
Evaluate how a translation error could affect safety, performance, regulatory acceptance, clinical evidence, data integrity, or user behavior. Warnings, alarms, contraindications, dosing information, operating steps, and field safety communications normally require stronger controls than low-risk internal content.
3. Prepare a translation-ready source
Remove ambiguity and inconsistency before translation. Define acronyms, standardize warnings, confirm units and symbols, supply editable files, identify variables, link screenshots to strings, and freeze an approved source revision. Clear source writing reduces queries and prevents the same defect from spreading to every language.
4. Build controlled linguistic assets
Create a device-specific glossary, style guide, translation memory, abbreviation list, product-name rules, and approved reference set. Include clinical, anatomical, engineering, software, regulatory, and user-facing terms. Mark terms that must not be translated and specify how numbers, units, punctuation, and warnings are handled.
5. Assign qualified medical-device linguists
Match translators and reviewers to the language, locale, device area, audience, and content risk. Native-language ability alone is insufficient. The team should understand the device context, technical concepts, regulatory purpose, file type, and applicable quality requirements.
6. Translate, review, and resolve queries
Use approved terminology and references, then conduct an independent bilingual review for high-impact content. Check accuracy, completeness, instructions, warnings, numbers, units, symbols, variables, register, readability, and consistency. Route technical questions to authorized subject-matter experts and record the decisions.
7. Perform automated and final-format QA
Automated checks can detect missing text, inconsistent terms, number mismatches, forbidden wording, tags, and formatting patterns. They do not replace qualified human judgment. Review the translated IFU, label, package, PDF, or screen in its delivered context for truncation, fonts, line breaks, tables, callouts, graphics, legibility, and right-to-left behavior.
8. Test localized software and devices
For embedded software, SaMD, apps, and portals, test on representative devices and configurations. Verify alarms, prompts, units, input fields, variables, branching, accessibility, character rendering, offline states, error messages, screenshots, and alignment with the approved IFU and labeling.
9. Control in-country review and approval
Give local reviewers a defined remit, the source, context, glossary, and deadline. Separate objective errors from stylistic preferences. Linguistically validate accepted edits, update the approved assets, and obtain documented release authorization through the manufacturer’s quality process.
10. Maintain an audit-ready release package
Retain the approved source and target files, language scope, translator and reviewer qualifications, query log, terminology decisions, QA reports, approvals, certificates where required, and released artwork or builds. A traceability matrix should connect each language version to its source revision and destination market.
How to Manage Updates After Launch
Translation control continues throughout the device lifecycle. A design change, new warning, complaint trend, cybersecurity update, software release, corrective action, or revised regulatory requirement can affect multiple multilingual assets.
- Compare each new source with the previously approved version.
- Assess the impact across IFUs, labels, software, training, websites, and field communications.
- Reuse only validated translations that still match the concept and context.
- Prioritize safety-critical changes and confirm market deadlines.
- Retire obsolete files and prevent accidental distribution.
- Keep previous eIFU versions available where the applicable rules require them.
- Feed complaints and reviewer findings into CAPA, terminology, and future releases.
Can AI Be Used for Medical Device Translation?
AI and machine translation can support selected tasks, but they do not remove manufacturer or reviewer accountability. Suitability depends on the content risk, language pair, available reference data, confidentiality, intended use, and validated performance.
- Classify content before allowing AI or machine translation.
- Use approved, secure systems with defined data-retention and access controls.
- Protect personal, confidential, and premarket information.
- Test performance by language, content type, device area, and error severity.
- Lock terminology and protect numbers, units, tags, variables, and warnings.
- Require qualified human review for regulated and safety-relevant content.
- Record the technology, version, settings, inputs, reviewer, and approval when traceability is required.
- Monitor omissions, hallucinations, terminology drift, and degradation after updates.
AI may improve throughput for repetitive or lower-risk material within a controlled workflow. It should not be used as an uncontrolled shortcut for IFUs, labeling, alarms, safety notices, clinical content, or submissions.
How to Choose a Medical Device Translation Provider
- Relevant expertise: experience with the device type, clinical area, content, audience, and target countries.
- Quality controls: documented linguist qualification, independent review, issue escalation, CAPA, and audit support.
- Regulatory awareness: a process for maintaining current language requirements without making unsupported legal claims.
- Technology capability: secure TMS, translation memory, terminology, structured content, DTP, software files, and automation.
- Testing services: final-format linguistic QA, functional testing, screenshots, and defect management.
- Security and privacy: access control, encryption, hosting transparency, retention rules, incident response, and subcontractor oversight.
- Lifecycle support: version comparison, delta translation, market-specific releases, urgent safety updates, and archival continuity.
- Measurable performance: on-time delivery, first-pass acceptance, defect severity, terminology compliance, and recurring root causes.
Ask each provider to demonstrate how one real deliverable moves from intake to approved release. The response should explain source control, terminology, translator qualifications, review, technical queries, QA, in-context testing, security, versioning, and retained evidence.
Medical Device Translation Cost and Timeline Factors
Cost and turnaround depend on the languages, word count, repetition, device complexity, source quality, risk level, review stages, file formats, DTP, software testing, screenshots, in-country review, certificates, and release schedule. A short label with several approval and artwork stages may take longer than a larger editable document.
Plan backward from submission, production, and launch dates. Stable source content, approved terminology, reusable translation memory, structured files, and clear reviewer roles reduce rework. Late changes, scanned PDFs, fragmented feedback, and inconsistent source terminology increase it.
Medical Device Translation FAQs
Which languages are required for a medical device in the EU?
The required languages depend on each Member State, the type of information, and whether the user is a patient, lay person, or professional. Confirm the current national provisions for every target country rather than assuming one EU-wide list.
Do U.S. medical-device labels have to be in English?
FDA generally requires labeling in English, with limited exceptions for products distributed solely in certain U.S. territories. If another language appears in the labeling, all required information must also appear in that language.
Is ISO 13485 certification required for a translation provider?
Not universally. The manufacturer should qualify suppliers according to its quality system and the outsourced activity’s risk. Certification can provide useful evidence, but it does not replace evaluation of competence, processes, security, performance, and project-specific controls.
What is the difference between translation and linguistic validation?
Translation produces target-language content. Linguistic validation adds evidence that the intended audience understands a concept or instrument as intended, often through a defined multistep process. It is common for certain clinical outcome assessments but is not automatically required for every device document.
Can an IFU be supplied only electronically?
Only when the device and circumstances meet the applicable legal conditions. In the EU, Regulation 2021/2226 limits eligibility and requires specific risk, access, website, language, version, and paper-request controls.
How should translated medical-device software be tested?
Test the localized build in context. Check complete and accurate strings, alarms, variables, units, layouts, text expansion, fonts, bidirectional behavior, accessibility, workflows, error states, and alignment with approved labeling and IFUs.
Build a Controlled Multilingual Device Program
Medical device translation is most reliable when regulatory, quality, product, engineering, medical, and language teams work within one controlled lifecycle. Define the market requirements, make the source translation-ready, apply risk-based review, test the final user experience, and preserve evidence for every released language.
AsiaLocalize supports regulated multilingual programs through specialized life sciences translation services, a documented translation and quality process, and regional language expertise. Request a tailored quote for your device, documents, software, languages, markets, and release schedule.
